The growing competition between the United States and China in the biotechnology sector has sparked concern among U.S. lawmakers regarding potential threats to national security and commercial interests. While some argue for stricter measures against Chinese companies, others caution that such restrictions may impede scientific progress and economic benefits.
Biotechnology holds immense promise for revolutionizing various aspects of everyday life, from medical treatments to genetic engineering in agriculture. Both the Chinese and U.S. governments have acknowledged the strategic importance of the biotech industry, prompting legislative action to regulate foreign companies with potential security risks.
